These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 9070163)
21. Focus on hyperlipidaemia. Rational and practical guidelines for reducing the risk of coronary heart disease. DiBianco R S Afr Med J; 1992 Feb; Suppl():1-9. PubMed ID: 1542809 [No Abstract] [Full Text] [Related]
22. [Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations]. Idzior-Waluś B Przegl Lek; 1999; 56(5):372-6. PubMed ID: 10554575 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular risk assessment and hyperlipidemia. Becker J Crit Care Nurs Clin North Am; 2008 Sep; 20(3):277-85. PubMed ID: 18644510 [TBL] [Abstract][Full Text] [Related]
24. Controversies in primary prevention among hyperlipidemic patients. McPherson R Can J Cardiol; 1999 Apr; 15 Suppl B():16B-19B. PubMed ID: 10350678 [TBL] [Abstract][Full Text] [Related]
25. Impact of multiple risk factors on coronary artery disease: beyond total cholesterol. Introduction. Gotto AM Am J Cardiol; 1998 Nov; 82(9A):1Q-2Q. PubMed ID: 9819097 [No Abstract] [Full Text] [Related]
26. Prevention of coronary heart disease: a nonhormonal approach. Lewis V; Hoeger K Semin Reprod Med; 2005 May; 23(2):157-66. PubMed ID: 15852201 [TBL] [Abstract][Full Text] [Related]
27. Management of dyslipidemia. Akel MM; Salti I J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421 [No Abstract] [Full Text] [Related]
28. Coronary artery disease and women: applying the guidelines for risk factor management. McPherson R Can J Cardiol; 2000 Jan; 16 Suppl A():5A-10A. PubMed ID: 10653924 [TBL] [Abstract][Full Text] [Related]
29. Hyperlipoproteinemia and coronary heart disease. Stone NJ; Levy RI Prog Cardiovasc Dis; 1972 Jan; 14(4):341-59. PubMed ID: 4550861 [No Abstract] [Full Text] [Related]
30. Hyperlipidaemia and the prevention of coronary heart disease. Scott RS; Lintott CJ; Bremer J; Nye ER N Z Med J; 1987 Nov; 100(836):717-9. PubMed ID: 3452167 [No Abstract] [Full Text] [Related]
34. "Metabolic syndrome" targeted in new US cholesterol guidelines. Larkin M Lancet; 2001 May; 357(9268):1594. PubMed ID: 11377654 [No Abstract] [Full Text] [Related]
35. [The value of the treatment of dyslipidemias in the prognosis of patients with coronary artery disease]. Giannini SD; Forti N; Issa JS; Diament J Arq Bras Cardiol; 1995 Sep; 65(3):297-9. PubMed ID: 8579521 [No Abstract] [Full Text] [Related]
36. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. Genest J; Frohlich J; Fodor G; McPherson R; CMAJ; 2003 Oct; 169(9):921-4. PubMed ID: 14581310 [No Abstract] [Full Text] [Related]
37. [Diabetes and coronary heart disease frequently appear together. New guidelines regulate therapy and prevention]. MMW Fortschr Med; 2006 Oct; 148(41):10-1. PubMed ID: 17190248 [No Abstract] [Full Text] [Related]
38. Assessing risk for coronary heart disease: beyond Framingham. Cobb FR; Kraus WE; Root M; Allen JD Am Heart J; 2003 Oct; 146(4):572-80. PubMed ID: 14564309 [No Abstract] [Full Text] [Related]
39. [Hyperlipidemia: therapeutic principles in clinical practice]. Müller-Wieland D; Krone W Med Klin (Munich); 2003 Dec; 98(12):739-43. PubMed ID: 14685674 [TBL] [Abstract][Full Text] [Related]
40. USPSTF scales back approach to lipid screening for women. Campos-Outcalt D J Fam Pract; 2008 Nov; 57(11):740-2. PubMed ID: 19006623 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]